SERPINA1
Assets acting on this target.
- Class
- SERPINA1 (Z-AAT) mRNA-targeting RNAi therapeutic
By indication
Related mechanisms
SERPINA1 drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Fazirsiran | Arrowhead Pharmaceuticals, Takeda Pharmaceutical Company | RNAi (siRNA) | Phase 3 | Phase 3 in Alpha-1 Antitrypsin Deficiency |
| TSRA-196 | Regeneron Pharmaceuticals | gene editing | Phase 1/2 | Phase 1/2 in Alpha-1 Antitrypsin Deficiency |